4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-05-000017
Sr. VP Research & Development bought 9,000 shares at $6.31 ($56,790)
From the SEC's structured data for this filing
Trades in this filing
LEVY MICHAEL D · Sr. VP Research & Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2005-05-12 | Purchase : show line 1 in the form | +9,000 | $6.31 | $56,790 | 9,000 | D |
| Open-market purchases · 9,000 sh · avg $6.31 · $56,790 | ||||||
Loading xslF345X02/edgar.xml…